|
| |
Efficacy and safety of memantine in patients with
mild to moderate vascular dementia
Orgogozo JM, Rigaud AS, Stoffler A, Mobius HJ, Forette F.
CHU Pellegrin,
Bordeaux, France.
j.m.orgogozo@neuro.u-bordeaux2.fr
Stroke 2002 Jul;33(7):1834-9
Abstract
BACKGROUND AND PURPOSE: Based on the hypothesis of glutamate-induced neurotoxicity (excitotoxicity) in cerebral ischemia, this study examined the efficacy and tolerability of memantine, an uncompetitive N-methyl-D-aspartate antagonist, in the treatment of mild to moderate vascular dementia.
METHODS: In this multicenter, 28-week trial carried out in France, 321 patients received 10 mg/d memantine or placebo twice a day; 288 patients were valid for intent-to-treat analysis. Patients had to meet the criteria for probable vascular dementia and have a Mini-Mental State (MMSE) score between 12 and 20 at inclusion. The 2 primary end points were the cognitive subscale of the Alzheimers Disease Assessment Scale (ADAS-cog) and the global Clinician's Interview Based Impression of Change
(CIBIC-plus).
RESULTS: After 28 weeks, the mean ADAS-cog scores were significantly improved relative to placebo. In the intention-to-treat population, the memantine group mean score had gained an average of 0.4 points, whereas the placebo group mean score had declined by 1.6 points, ie, a difference of 2.0 points (95% confidence interval, 0.49 to 3.60). The response rate for CIBIC-plus, defined as improved or stable, was 60% with memantine compared with 52% with placebo (P=0.227, intention to treat). Among the secondary efficacy parameters, which were analyzed in the per-protocol subset, MMSE was significantly improved with memantine compared with deterioration with placebo (P=0.003). The Gottfries-Brane-Steen Scale intellectual function subscore and the Nurses' Observation Scale for Geriatric Patients disturbing behavior dimension also showed differences in favor of memantine (P=0.04 and P=0.07, respectively). Memantine was well tolerated with a frequency of adverse events comparable to placebo.
CONCLUSIONS: In patients with mild to moderate vascular dementia, memantine 20 mg/d improved cognition consistently across different cognitive scales, with at least no deterioration in global functioning and behavior. It was devoid of concerning side effects.
|
|
|
order
|
|
Galantamine Alzheimer's
articles
www.AlzheimersTreatments.com
Galantamine fights Alzheimer's
In
the 1950s, a Bulgarian pharmacologist noticed that local villagers rubbed their
foreheads with
the snowdrop plant to ease
nerve pain. Further investigation led to the isolation of the snowdrop extract
galantamine continue
Galantamine: why galantamine is the best agent for restoring memory
Galantamine has several advantages over donepezil (Aricept®) and rivastigmine (Exelon®)
continue
Galantamine: can sharpen your mental edge
Galantamine's positive results
in slowing the progression of Alzheimer's disease may be due continue
Galantamine: helps save Memory
Galantamine is used in treating Alzheimer's disease, because of its ability
continue
Galantamine: beats Prescription Drugs for
combating Mental Decline
Galantamine is different from donepezil (Aricept®) and rivastigmine (Exelon®) in one very important
way, galantamine has the unique ability to increase the receptiveness of nicotinic
receptors to acetylcholine continue
Galantamine: opens the channels of your Memory
The secret
of galantamine's success lies in your brain's nicotinic receptors. continue
Galantamine: Protect Brain Function by Enhancing Neurotransmission
Galantamine has been found to be effective in treating Alzheimer's
disease continue
Galantamine:
Boost Memory
Galantamine achieves the same effect as drugs such as
Aricept or tacrine, but has additional benefits continue
Galantamine protects Brain funtion
The
primary objective with
Alzheimer's is to enhance neurotransmission so as to retain memory continue
Galantamine:
food for Mind & Body
Galantamine is a
flower extract that improves memory and perhaps even helps with impotence continue
Galantamine may help stave off Dementia
Dementia
is a progressive loss of memory accompanied by significant continue
Galantamine: Memory Enhancement
Alzheimer's patients suffer sharp declines in their brain levels of acetylcholine.
Galantamine continue
Galantamine rescues
Brain Cells
According to a study of 653 Alzheimer's disease
patients published in the
British Medical Journal, the herbal supplement galantamine
"appears to slow the progression of the neurodegenerative
condition" continue
Galantamine:
the Old Become Young
As we age, it becomes harder to
learn new things. One explanation is the deterioration of the brain's
continue
Galantamine: What's Old with Acetylcholine is New to Us
Acetylcholine
deficiency is
characteristic of Alzheimer's disease. The primary treatment is administration
of agents like galantamine, an extract from the snowdrop and
daffodil plants continue
|
|